Pfizer plans four-part offering of notes

By Cristal Cody

Tupelo, Miss., May 12 - Pfizer Inc. intends to bring a four-tranche offering of notes, according to a preliminary prospect supplement filed with the Securities and Exchange Commission on Monday.

The deal includes notes due 2017, notes due 2019, notes due 2024 and notes due 2044.

BofA Merrill Lynch, Barclays, Deutsche Bank Securities Inc. and J.P. Morgan Securities LLC are the underwriters.

Proceeds will be used for general corporate purposes, including pre-funding outstanding debt.

Pfizer is a New York City-based biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.